These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 19483645

  • 1. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.
    Hayden H, Friedl J, Dettke M, Sachet M, Hassler M, Dubsky P, Bachleitner-Hofmann T, Gnant M, Stift A.
    J Immunother; 2009; 32(6):638-54. PubMed ID: 19483645
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cryopreservation of monocytes or differentiated immature DCs leads to an altered cytokine response to TLR agonists and microbial stimulation.
    Meijerink M, Ulluwishewa D, Anderson RC, Wells JM.
    J Immunol Methods; 2011 Oct 28; 373(1-2):136-42. PubMed ID: 21878338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
    Bohnenkamp HR, Burchell JM, Taylor-Papadimitriou J, Noll T.
    J Immunol Methods; 2004 Nov 28; 294(1-2):67-80. PubMed ID: 15604017
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M.
    Int J Oncol; 2006 Nov 28; 29(5):1263-8. PubMed ID: 17016660
    [Abstract] [Full Text] [Related]

  • 9. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A, Van de Velde AL, Nijs G, Braeckman T, Stein B, De Vries JM, Berneman ZN, Van Tendeloo VF.
    Cytotherapy; 2009 Nov 28; 11(5):653-68. PubMed ID: 19530029
    [Abstract] [Full Text] [Related]

  • 10. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion.
    Eljaafari A, Li YP, Miossec P.
    J Immunol; 2009 Sep 01; 183(5):2932-45. PubMed ID: 19696431
    [Abstract] [Full Text] [Related]

  • 11. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F, van Baal JW, Rygiel AM, Bergman JJ, Van Deventer SJ, Kapsenberg ML, Peppelenbosch MP, Krishnadath KK.
    J Immunol Methods; 2007 Apr 10; 321(1-2):94-106. PubMed ID: 17336322
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells: limited potential in immunotherapy.
    Soruri A, Zwirner J.
    Int J Biochem Cell Biol; 2005 Feb 10; 37(2):241-5. PubMed ID: 15474968
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.
    Tuyaerts S, Michiels A, Corthals J, Bonehill A, Heirman C, de Greef C, Noppe SM, Thielemans K.
    Cancer Gene Ther; 2003 Sep 10; 10(9):696-706. PubMed ID: 12944989
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM.
    Vaccine; 2008 Jun 02; 26(23):2824-32. PubMed ID: 18450338
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy.
    Heo YJ, Son CH, Chung JS, Park YS, Son JH.
    Cryobiology; 2009 Apr 02; 58(2):203-9. PubMed ID: 19152796
    [Abstract] [Full Text] [Related]

  • 19. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S, Ju S, Ge Y, Qiu H, Lu B, Qiu Y, Fu J, Liu G, Wang Q, Hu Y, Shu Y, Zhang X.
    Int Immunol; 2009 Oct 02; 21(10):1135-44. PubMed ID: 19684160
    [Abstract] [Full Text] [Related]

  • 20. Differentiation of monocyte-derived dendritic cells under the influence of platelets.
    Nguyen XD, Müller-Berghaus J, Kälsch T, Schadendorf D, Borggrefe M, Klüter H.
    Cytotherapy; 2008 Oct 02; 10(7):720-9. PubMed ID: 18985478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.